Streetbeat News

Stock Prices

MSAI

Shares of MultiSensor AI (MSAI) were halted due to a circuit breaker after surging 42.5%. This significant price movement triggered a temporary trading pause to manage volatility.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 7:10 pm

MSAI

MultiSensor AI Holdings, Inc. (NASDAQ:MSAI) announced the release of SmartIR 2.0, an advanced AI-powered software for predictive maintenance and process control in industrial settings. The new version features expanded sensor modalities, enhanced AI analytics, live multi-region temperature monitoring, extended sensor data capture, advanced computer vision tools, and expanded EAM integrations. These improvements aim to boost asset reliability, process control, and employee safety across various industries.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 7:09 pm

FSLY

Fastly, Inc. (NYSE:FSLY) shares dropped after reporting mixed Q4 financial results and guidance. Earnings per share were at 1 cent, beating estimates, but quarterly sales of $137.78 million missed expectations. Analyst Jeff Van Rhee downgraded Fastly from Buy to Hold with a $20 price target. The stock's heavy trading volume was noted, and its FY23 revenue growth was 16.93%. Economic conditions and comparisons with peers were discussed, highlighting Fastly's underperformance in the Information Technology sector.

Portfolio Pulse from Erica Kollmann

February 15, 2024 | 7:08 pm

AAPL

META

SPOT

Meta Platforms Inc (NASDAQ:META) has introduced guidelines for small businesses to bypass Apple Inc's (NASDAQ:AAPL) App Store commissions by purchasing ads through a web browser. This move, aimed at avoiding Apple's up to 30% cut from in-app purchases, escalates the rivalry between the two tech giants. Apple's strict policies have been criticized by other companies as well, including Spotify Technology SA (NYSE:SPOT). Meta's ad revenue has been significantly impacted by Apple's privacy changes, with an estimated loss of $10 billion. The new ad purchasing policy will initially apply in the U.S. and expand to other regions later this year.

Portfolio Pulse from Anusuya Lahiri

February 15, 2024 | 7:06 pm

GLUE

RHHBY

Wedbush initiated coverage on Monte Rosa Therapeutics Inc (NASDAQ:GLUE) with an Outperform rating and a price target of $11, highlighting the company's AI/ML-based QuEEN platform and its lead asset, MRT-2359, for cancer and autoimmune diseases. Monte Rosa's strategic collaboration with Roche Holdings AG (OTC:RHHBY) could bring in over $2 billion in milestone payments plus royalties. GLUE shares rose 14.29% to $5.44.

Portfolio Pulse from Vandana Singh

February 15, 2024 | 7:05 pm

EPAM

EPAM Systems, Inc. (NYSE:EPAM) reported a 6.0% year-on-year decline in Q4 FY23 sales to $1.16 billion, surpassing analyst estimates. Adjusted EPS was $2.75, beating the consensus of $2.50. The company provided strong Q1 revenue guidance and expects 2024 revenue growth of 1% - 4%. Following the report, EPAM shares rose 7.8% to $300.01. Analysts from Piper Sandler and Needham raised their price targets on EPAM, maintaining Overweight and Buy ratings respectively.

Portfolio Pulse from Avi Kapoor

February 15, 2024 | 7:04 pm

KO

The Coca-Cola Company (KO) has announced a 5.4% increase in its quarterly dividend, from $0.46 to $0.485 per share, marking its 62nd consecutive annual dividend increase. This adjustment raises the annual dividend to $1.94 per share from $1.84 in 2023. The first quarter dividend will be payable on April 1 to shareholders of record as of March 15. In 2023, Coca-Cola returned $8 billion in dividends, with a total of $84.7 billion paid out since 2010.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 7:02 pm

PFE

Pfizer Inc. (NYSE:PFE) reported mixed results in its Q4 2023 earnings call, highlighting a year of contrasts. Despite setbacks in COVID-19 product revenues, Pfizer achieved market leadership in pharma-only products, a record number of FDA approvals, and successfully closed the Seagen acquisition. However, missed projections, significant sales declines in COVID-19 products, a 93% dip in full-year diluted EPS, and nearly $1 billion in impairment charges for Prevnar 13 were notable negatives.

Portfolio Pulse from Tornado

February 15, 2024 | 7:01 pm

TIAUSD

Celestia's cryptocurrency (TIA) has seen a 3.82% decrease in price over the last 24 hours, marking a continuation of its 10% decline over the past week. The trading volume for TIA has decreased by 30%, despite a 1.05% increase in circulating supply, now at 164.50 million. Currently, TIA's market cap ranks #37 at $3.03 billion.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 7:00 pm